Upstream Bio, Inc. (UPB) - Company Total Revenue
Upstream Bio Inc (UPB) relies on outsourcing antibody production while maintaining sufficient capital to complete drug trials. On the GURU.Markets platform, the company's sales volume dynamics demonstrate market positions where the value of 0.00 characterizes this level. However, geopolitical tensions and logistics disruptions create risks for conducting international tests, which could lead to financial losses.
Analytical breakdowns for Upstream Bio (UPB)
- current price and projected stock value:
- market capitalization indicators:
- book value of equity indicators:
- debt obligations and liquidity statistics:
- net income and valuation ratios data:
UPB - Company Net Income|Future Profit Upstream Bio Inc|UPB - Price to Earnings Ratio|Future Price to Earnings Multiple upstreambio.com|UPB - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Upstream Bio Inc|UPB - Operating profit EBITDA|Net earnings per share for the last four quarters Upstream Bio|UPB - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months upstreambio.com|UPB - Net earnings per share growth this year|Expected earnings per share trend next year Upstream Bio Inc
- sales volume and revenue indicators:
Comprehensive company analysis:Upstream Pharma - UPB
Investors must find a balance between operational risks and the future return on invested capital. Upstream Bio Inc (UPB) is currently focusing on R&D antibody development, utilizing IPO proceeds to cover expenses. An analysis of the company's monthly sales converts gross revenue into a continuous curve, reflecting the product realization rate. Growth in this indicator signals an expansion of market share. The current absence of revenue confirms a stage of planned reserve consumption.
Key competitors
Company Sales Volume ARGX (argenx BVBA)|Revenue and Sales Volume BNTX|ABVX - Company Total Revenue|ADMA Biologics, Inc. - Company Sales|Revenue and Sales Volume Protagonist Therapeutics, Inc. PTGX|IMVT - Company Revenue|Company Annual Revenue KNSA|Grifols, S.A. (GRFS) - Company Revenue|ADPT - Company Gross Revenue|Company Sales CLDX|AUPH (Aurinia Pharmaceuticals Inc) - Company Total Sales|Company Revenue BioCryst Pharmaceuticals Inc (BCRX)|VERA (Vera Corp) - Company Sales Revenue|Revenue and Sales Volume DNTH (Dianthus Therapeutics)|pharvaris.com (PHVS) - Company Total Revenue|AbCellera - Revenue and Sales Volume|TRML - Revenue and Sales Volume|Intrexon (PGEN) - Company Revenue|Company Sales Pharming Corp|Company Sales NKTR|ZBIO: Company Sales Revenue|Revenue and Sales Volume IMNM|Company Revenue GOSS (Gossamer Bio Inc)|Revenue and Sales Volume KALV (KalVista Pharmaceuticals Inc)|Company Gross Revenue Septerna Pharma (SEPN)|PVLA - Company Revenue|Company Total Revenue savarapharma.com|RIGL (Rigel Pharmaceuticals, Inc.) - Company Sales|AnaptysBio Inc - Company Sales Revenue|ATXS (Astria Pharma) - Revenue and Sales Volume|enGene Corp (ENGN) - Company Gross Revenue|Company Revenue RAPT Therapeutics, Inc. (RAPT)|aerovatetx.com - Company Sales Volume|Revenue and Sales Volume ACRS (Aclaris Therapeutics, Inc.)|KYTX - Company Sales|TLSA: Company Sales|CABA - Revenue and Sales Volume|Ventyx Biosciences (VTYX) - Company Revenue|Company Annual Revenue THTX (theratech.com)|AVTX (Avalo Therapeutics) - Revenue and Sales Volume|Company Revenue ELDN|Company Revenue Agenus Inc (AGEN)|CLYM: Company Annual Revenue|Revenue and Sales Volume ZURA (Zura Bio Limited)|Company Sales Revenue ATYR|Adagene Corp - Revenue and Sales Volume|IMA - Revenue and Sales Volume|shattucklabs.com (STTK) - Company Revenue|Equillium - Company Sales Revenue|Company Revenue Connect Biopharma Holdings|Company Sales Immunic Inc (IMUX)|Revenue and Sales Volume ATRA|Revenue and Sales Volume inflarx.de (IFRX)|X4 Pharma - Company Sales|Company Sales Revenue ACET|Celularity Corp - Revenue and Sales Volume|Company Gross Revenue inmunebio.com INMB|Barinthus Biotherapeutics plc (BRNS) - Company Revenue|Company Sales Kezar Life Sciences Inc.|Company Revenue SAB Biotherapeutics, Inc|Company Sales Akari Therapeutics, Plc (AKTX)|Company Sales ENLV (Enlivex Therapeutics)|Revenue and Sales Volume q32bio.com (QTTB)|Company Revenue GeoVax GOVX|EDSA: Company Sales Volume|iBio Corp - Revenue and Sales Volume|Company Total Revenue Carisma Therapeutics|XTLB (XTL Biopharmaceuticals) - Company Sales|Bolt Biotherapeutics, Inc. (BOLT) - Revenue and Sales Volume|Company Revenue HCW Biologics, Inc.|Aptevo - Company Annual Revenue|Company Revenue AIM ImmunoTech (AIM)|Company Gross Revenue aditxt.com|GRI Bio, Inc. - Company Sales|Company Total Sales XRTX (xortx.com)|HIND - Company Revenue|Company Sales Revenue REVB (Revelation Biosciences Inc)|INDP: Revenue and Sales Volume|Company Total Revenue BiondVax Pharmaceuticals (SCNI)|CALI (CalciMedica Inc) - Revenue and Sales Volume|Revenue and Sales Volume Affimed Therapeutics|Company Revenue Allakos Inc. (ALLK)|Company Sales hookipapharma.com HOOK|IGM Biosciences - Company Sales|Company Sales Revenue ITOS|Ocean Biomedical, Inc. - Revenue and Sales Volume|TCBP: Company Revenue|THRD: Revenue and Sales Volume
